Although this mechanism has not been directly validated in colorectal cancer (CRC), our findings suggest that HDAC3 may similarly regulate NRF2 expression at the epigenetic level in CRC cells, thereby modulating downstream targets such as GPX4 and contributing to ferroptosis resistance. This evidence concerns the gene GPX4 and colorectal carcinoma.